Key result
Genome-wide screen identifies 256 host factors regulating EV71 replication, highlighting CDK6 and AURKB resistance.
Why the study?
Enterovirus 71 lacks antivirals or vaccines and its host-pathogen interactions are poorly understood.
No immediate clinical implications for EV71; leaves open whether CDK6, AURKB, or NGLY1 modulation offers viable antiviral strategies.
Enterovirus 71 (EV71) is a neurotropic enterovirus without antivirals or vaccine, and its host-pathogen interactions remain poorly understood. Here we use a human genome-wide RNAi screen to identify 256 host factors involved in EV71 replication in human rhabdomyosarcoma cells. Enrichment analyses reveal overrepresentation in processes like mitotic cell cycle and transcriptional regulation. We have carried out orthogonal experiments to characterize the roles of selected factors involved in cell cycle regulation and endoplasmatic reticulum-associated degradation. We demonstrate nuclear egress of CDK6 in EV71 infected cells, and identify CDK6 and AURKB as resistance factors. NGLY1, which co-localizes with EV71 replication complexes at the endoplasmatic reticulum, supports EV71 replication. We confirm importance of these factors for EV71 replication in a human neuronal cell line and for coxsackievirus A16 infection. A small molecule inhibitor of NGLY1 reduces EV71 replication. This study provides a comprehensive map of EV71 host factors and reveals potential antiviral targets.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2016) studied Enterovirus 71 (EV71) infection. Genome-wide RNAi screen and small molecule inhibitors vs. Non-targeting siRNA or DMSO control was evaluated on EV71 replication (infection rate). A human genome-wide RNAi screen identified 256 host factors involved in EV71 replication, revealing that CDK6 and AURKB act as resistance factors while NGLY1 supports replication.